Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Yongkang Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-9936-4516; OpenAlex author ID A5045252627. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 5

  1. USP20-RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake. Co-author DOI 10.1016/j.canlet.2026.218299↗
  2. Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3. Co-author DOI 10.1038/s41418-026-01665-1↗
  3. Post-Translational Modifications: Key "Regulators" of Pancreatic Cancer Malignant Phenotype-Advances in Mechanisms and Targeted Therapies. Co-author DOI 10.3390/biomedicines13123013↗
  4. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-022-01040-w↗
  5. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation. Co-author DOI 10.1186/s13046-022-02491-2↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Renyi Qin · 5 shared papers, 2022–2026 · strength 1.21
  2. Zhenxiong Zhang · 4 shared papers, 2022–2026 · strength 0.78
  3. Shutao Pan · 3 shared papers, 2022–2026 · strength 0.55
  4. Jun Gong · 3 shared papers, 2022–2026 · strength 0.55
  5. Min Wang · 3 shared papers, 2022–2026 · strength 0.55
  6. Chunle Zhao · 3 shared papers, 2022–2026 · strength 0.55
  7. Taoyuan Yin · 3 shared papers, 2022–2026 · strength 0.55
  8. Yu Bai · 2 shared papers, 2026 · strength 0.49
  9. Yiming Li · 1 shared paper, 2025 · strength 0.42
  10. Min Zhou · 2 shared papers, 2023–2026 · strength 0.41
  11. Yuhui Liu · 1 shared paper, 2023 · strength 0.16
  12. Xingjun Guo · 1 shared paper, 2022 · strength 0.13
  13. Min Zhou · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.